Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-23

Clinical Trial Update: Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI [Phase 3]

View source ↗

Summary

Phase 3 placebo-controlled trial of Nolasiban to improve pregnancy rates in women undergoing IVF/ICSI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nolasiban

Snippet

Sponsor: ObsEva SA | Conditions: Infertility | Phase 3 | Status: COMPLETED